Agmatine: a novel endogenous vasodilator substance

Life Sci. 1995;57(8):PL83-6. doi: 10.1016/0024-3205(95)02011-7.

Abstract

The purpose of the study was to investigate the effects of agmatine, an endogenous clonidine-displacing substance (CDS), on systemic hemodynamics in the anesthetized rat. Bolus intravenous (i.v.) injections of agmatine decreased systemic arterial pressure (SAP) and systemic vascular resistance in a dose-dependent manner. The development of acute tachyphylaxis to the systemic vasodepressor response to agmatine did not induce cross-tachyphylaxis to the systemic vasodepressor responses to bradykinin, isoproterenol and nitroglycerin. The present data demonstrate agmatine, as a CDS and agonist for imidazoline (I) receptors, possesses marked systemic vasodilator activity in the rat. The present data suggest that activation of I receptors may represent a novel mechanism of vasodilation in vivo.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Agmatine / pharmacology*
  • Animals
  • Female
  • Hemodynamics / drug effects
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Tachyphylaxis
  • Vasodilator Agents / pharmacology*

Substances

  • Vasodilator Agents
  • Agmatine